Home › Rating Schedule › Hemic and Lymphatic Systems
Diagnostic Code 7723: Acquired hemolytic anemia
Hemic and Lymphatic Systems · 38 CFR §4.117 · All codes in this system
| Evaluation criteria | Rating |
|---|---|
| Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab) | 100% |
| Requiring immunosuppressive medication 4 or more times per 12-month period | 60% |
| Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period | 30% |
| Requiring one course of immunosuppressive therapy per 12-month period | 10% |
| Asymptomatic | 0% |
| Note (1): A 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission and shall continue for six months after hospital discharge with a mandatory VA examination six months following hospital discharge. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of ยง 3.105(e) of this chapter | |
| Note (2): Separately evaluate splenectomy under diagnostic code 7706 and combine with an evaluation under diagnostic code 7723 | |
Use this rating
Open the combined ratings calculator with this percentage already entered, then add your other rated conditions:
100% in the calculator 60% in the calculator 30% in the calculator 10% in the calculator 0% in the calculator
Source: eCFR Title 38, 38 CFR §4.117, current as of 2026-11-05. Criteria text is the regulatory text, reproduced verbatim for reference; it is not legal advice.